XML 15 R46.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Segment Reporting Information        
Net Sales to External Customers $ 5,150 $ 5,079 $ 15,217 $ 14,891
Operating Earnings 713 728 2,052 1,770
Amortization of intangible assets (151) (132) (458) (392)
Earnings from continuing operations before taxes 714 715 2,353 1,714
Other        
Segment Reporting Information        
Net Sales to External Customers 572 611 1,689 1,828
Total Reportable Segments        
Segment Reporting Information        
Net Sales to External Customers 4,578 4,468 13,528 13,063
Operating Earnings 1,182 1,119 3,404 3,009
Total Reportable Segments | Established Pharmaceutical Products        
Segment Reporting Information        
Net Sales to External Customers 961 771 2,835 2,196
Operating Earnings 177 160 516 441
Total Reportable Segments | Nutritional Products        
Segment Reporting Information        
Net Sales to External Customers 1,789 1,787 5,175 5,149
Operating Earnings 459 369 1,198 954
Total Reportable Segments | Diagnostic Products        
Segment Reporting Information        
Net Sales to External Customers 1,156 1,180 3,426 3,486
Operating Earnings 307 310 887 810
Total Reportable Segments | Vascular Products        
Segment Reporting Information        
Net Sales to External Customers 672 730 2,092 2,232
Operating Earnings 239 280 803 804
Corporate functions        
Segment Reporting Information        
Corporate functions and benefit plans costs (109) (76) (330) (237)
Reconciling items        
Segment Reporting Information        
Non-reportable segments 76 124 193 297
Net interest expense (16) (17) (49) (54)
Share-based compensation [1] (43) (39) (248) (203)
Amortization of intangible assets (151) (132) (458) (392)
Other, net [2] $ (225) $ (264) $ (159) $ (706)
Minimum        
Segment Reporting Information        
Annual share-based awards recognized in first quarter (as a percent)     40.00%  
Maximum        
Segment Reporting Information        
Annual share-based awards recognized in first quarter (as a percent)     45.00%  
[1] Approximately 40 to 45 percent of the annual net cost of share-based awards will typically be recognized in the first quarter due to the timing of the granting of share-based awards.
[2] Other, net for the nine months ended September 30, 2015 includes a gain on the sale of a portion of Abbott’s position in Mylan N.V. stock and a decrease in the fair value of contingent consideration related to a business acquisition, which was partially offset by charges associated with cost reduction initiatives.